Lei Zhang

Dr. Lei Zhang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2016 in Scientific Reports
Verified
Journal Article
Open access
CYCaiting Yang
Caiting Yang
PPPeike Peng
Peike Peng
LLLili Li
Lili Li
MSMiaomiao Shao
Miaomiao Shao
JZJunjie Zhao
Junjie Zhao
JGJianxin Gu
Jianxin Gu
Pancreatic cancer is one of the most lethal of all types of cancer, with the 5-year survival rate ranging only at 6–7%. The aberrant glucose metabolism is one of the hallmarks of cancer cells, and as a branch of glucose metabolism, hexosamine biosynthesis pathway (HBP) has been reported to play a critical role in the insulin resistance and progression of cancer. Glutamine:fructose-6-phosphate amidotransferase (GFAT1) is the rate-limiting enzyme of the HBP; nevertheless, the prognostic value of GFAT1 in pancreatic cancer remains elusive. In this study, we found that the expression of GFAT1 was increased in pancreatic cancer samples compared to peri-tumor tissues. High expression of GFAT1 was positively associated with lymph node metastasis, pTNM stage and shorter overall survival (OS) in pancreatic cancer patients. GFAT1 was identified as an independent prognosticator for OS, and combining GFAT1 expression with pTNM stage generated a predictive nomogram, which showed better prognostic efficiency for OS in patients with pancreatic cancer. In summary, high GFAT1 expression is identified as an independent predictor of adverse clinical outcome in our small number of pancreatic cancer patients, and the practical prognostic nomogram model may help clinicians in decision making and the design of clinical studies.

10 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
HFHaokang Feng
Haokang Feng
JFJiale Feng
Jiale Feng
XHXu Han
Xu Han
YYYing Ying
Ying Ying
WLWenhui Lou
Wenhui Lou
LZLei Zhang
Lei Zhang
The dysregulation of sialic acid is closely associated with oncogenesis and tumor progression. Most tumor cells exhibit sialic acid upregulation. Sialic acid-binding immunoglobulin-like lectins (Siglecs) are receptors that recognize sialic acid and are expressed in various immune cells. The activity of Siglecs in the tumor microenvironment promotes immune escape, mirroring the mechanisms of the well-characterized PD-1/PD-L1 pathway in cancer. Cancer cells utilize sialic acid-linked glycans to evade immune surveillance. As Siglecs exhibit similar mechanisms as the established immune checkpoint inhibitors (ICIs), they are potential therapeutic targets for different forms of cancer, especially ICI-resistant malignancies. Additionally, the upregulation of sialic acid serves as a potential tumor biomarker. This review examines the feasibility of using sialic acid and Siglecs for early malignant tumor detection and discusses the potential of targeting Siglec–sialic acid interaction as a novel cancer therapeutic strategy.

1 July 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
BLBo Li
Bo Li
NPNing Pu
Ning Pu
QCQiangda Chen
Qiangda Chen
YMYong Mei
Yong Mei
DWDansong Wang
Dansong Wang
WLWenhui Lou
Wenhui Lou
Background: Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a severe and challenging complication of pancreaticoduodenectomy (PD). This study aimed to establish a novel postoperative nomogram-based diagnostic model for the early detection of CR-POPF in patients subjected to PD. Methods: Consecutive patients who underwent PD in Zhongshan Hospital, Fudan University from December 2018 to October 2020 were retrospectively enrolled. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for CR-POPF. Then, a novel predictive nomogram was established accordingly. Results: Among the consecutive 176 patients who underwent PD, 37 (21.1%) patients developed CR-POPF. Through univariate and multivariate analyses, the drain amylase (P = 0.002), serum creatinine (P = 0.009), and serum C reactive protein (P = 0.045) at postoperative day 1 (POD1) as well as the neutrophil count (P = 0.025) and temperature (P = 0.025) at POD3 were identified as independent risk factors for CR-POPF. Based on this, a novel predictive nomogram containing these factors was constructed to predict the probability of CR-POPF after PD. The formulated nomogram showed better performance to detect CR-POPF after PD with a sensitivity of 0.784, specificity of 0.770, positive predictive value of 0.475, and negative predictive value of 0.930 when compared to other predictors. In addition, the predictive value of the nomogram was assessed by a concordance index of 0.814 (95% CI, 0.736–0.892), which was significantly higher than indicators alone. This was further validated and depicted by decision curve analysis and clinical impact curve. Conclusion: This study established a diagnostic nomogram of postoperative objective parameters that can predict the development of CR-POPF after PD with a good discriminative ability and predictive accuracy.

1 January 2022 in Journal of Cancer
Verified
Journal Article
Open access
HWHuanyu Wang
Huanyu Wang
WMWeilin Mao
Weilin Mao
WLWenhui Lou
Wenhui Lou
DJDayong Jin
Dayong Jin
WWWenchuan Wu
Wenchuan Wu
LZLei Zhang
Lei Zhang
Background/Objectives: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignant tumor with an extremely poor prognosis in digestive tumors. Pyrroline-5-carboxylate reductase 1 (PYCR1) plays an important role in tumor development. Therefore, we aimed to explore the effect of PYCR1 on the growth of PDAC cells.

1 May 2022 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
ZWZhe Wang
Zhe Wang
TKTiantao Kuang
Tiantao Kuang
WWWenchuan Wu
Wenchuan Wu
DWDansong Wang
Dansong Wang
WLWenhui Lou
Wenhui Lou
LZLei Zhang
Lei Zhang
Original Article GFAT1 is highly expressed in cancer stem cells of pancreatic cancer Zhe Wang, Tiantao Kuang, Wenchuan Wu, Dansong Wang, Wenhui Lou, Dayong Jin, Xuefeng Xu, Lei Zhang

10 June 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
BHBo Hou
Bo Hou
NZNa Zhu
Na Zhu
JYJiamei Yao
Jiamei Yao
JYJuan Yu
Juan Yu
LZLei Zhang
Lei Zhang
XGXiaowen Ge
Xiaowen Ge
Introduction and importance: Crystal-storing histiocytosis (CSH) is a rare, non-neoplastic histiocytic proliferation that often complicates underlying lymphoproliferative or plasma cell disorders. The respiratory system is uncommonly involved in CSH. We present a local case of pulmonary CSH associated with marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT), along with eight additional cases identified from a literature review. Case presentation: A 64-year-old woman was admitted to the hospital for coughing, expectoration, and asthma for more than 1 year. Chest CT revealed localized thickening of the tracheal wall, and the bronchoscopy examination showed neoplasms of the trachea and bronchus mucosa. The lesion was characterized by sheets of histiocytes with abundant eosinophilic cytoplasm and scattered aggregates of atypical lymphoid cells. Immunohistochemical stains and T/B-cell gene rearrangement studies supported the pathological diagnosis of CSH-associated MALT. The patient remained free from the disease after lesion resection via bronchoscopy, with further treatment of targeted therapy. Clinical discussion: Pulmonary CSH-associated MALT can occur in patients of various ages and genders with non-specific clinical and imaging features. Histopathological examination is essential for differentiating CSH from similar conditions. The pathogenesis of CSH may relate to the overproduction of immunoglobulins, and the immunoglobulin types involved in the cases we described are predominantly kappa light chains. Conclusion: Recognizing CSH is essential for starting a clinical evaluation to identify the underlying neoplasm or associated causes. A conclusive diagnosis relies on pathological examination. More detailed case reports are needed to clarify pathogenesis and improve diagnosis, treatment strategies, and patient outcomes.